Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Reagents

JL Junyang Li
YZ Yali Zhou
HW Handong Wang
YG Yongyue Gao
LL Liwen Li
SH Sung Hee Hwang
XJ Xiangjun Ji
BH Bruce D Hammock
request Request a Protocol
ask Ask a question
Favorite

The cyclooxygenase (COX)-2/soluble epoxide hydrolase (sEH) dual inhibitor, PTUPB, was synthesized by Dr. Sung Hee Hwang as described [18, 47]. The recombinant human EGF (hEGF) (#8916) and primary antibodies against β-actin (#3700), CDK2 (#2546), p27Kip1 (#3686), Cyclin D3 (#2936), c-Myc (#13987), Cyclin D1 (#2978), p21Waf1/Cip1 (#2947), CDK4 (#12790), CDK6 (#3136), EGFR (#4267), p-EGFRTyr1068 (#3777), p-EGFRTyr1173 (#4407), AKT (#2920), p-AKTSer473 (#4060), ERK1/2 (#4695), p-ERK1/2Thr202/Tyr204 (#4377), GRB2 (#3972), BMI1 (#6964), ZEB1 (#3396) and SOX2 (#3579) were all purchased from Cell Signaling Technology (Beverly, MA, USA). Antibody against HMMR (#GTX121502) was purchased from GeneTex (Irvine, CA, USA).

Copyright and License information:  ©2017 Li et al.
This article is distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A